The IDEAL Randomised Controlled Trial

Not Applicable

Completed

• Conditions: Pregnant women with borderline gestational diabetes; Reproductive Health and Childbirth - Antenatal care

• Registration Number: ACTRN12607000174482
• Lead Sponsor: Women's and Children's Hospital, Adelaide, SA.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-03-19
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 682

Inclusion Criteria

Women between 24 weeks 0 days and 34 weeks 6 days gestation with a singleton pregnancy, with a positive OGCT (venous plasma glucose >=7.8 mmol/L) and a normal 75 gram OGTT (fasting venous plasma glucose <5.5 mmol/L and a 2 hour glucose <7.8 mmol/L), who give written, informed consent.

Exclusion Criteria

Women with known diabetes mellitus, previously treated GDM, active chronic systemic disease (except essential hypertension and mild forms of asthma) or a multiple pregnancy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of large for gestational age (LGA) infants defined as birthweight above the 90th centile for gestation and fetal sex on standardised birthweight charts.[Measured at birth]